GYRE vs TFX · rev $53.5M vs P/E 2083, rev $1.12B
Gyre Therapeutics Inc. (GYRE) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
GYRE currently screens at market cap $589.9M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the GYRE and TFX stock pages for the full models.
Not investment advice.